UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.921

Sortiert nach

0505 SLEEP APNEA BREATHING DISTURBANCES ARE ASSOCIATED WITH OBJECTIVE SLEEPINESS INDEPENDENT OF HYPOXIA

Sleep (New York, N.Y.), 2017-04, Vol.40 (suppl_1), p.A188-A188

2017

Volltextzugriff (PDF)

1-D and 2-D analyses of weak motion data in Fraser Delta from 1966 Duvall earthquake

Soil dynamics and earthquake engineering (1984), 2003-06, Vol.23 (4), p.323-329

2003

Volltextzugriff (PDF)

1 H, 13 C, 15 N resonance assignment of the apo form of the small, chitin-active lytic polysaccharide monooxygenase JdLPMO10A from Jonesia denitrificans

Biomolecular NMR assignments, 2021-04, Vol.15 (1), p.79

2021

Volltextzugriff (PDF)

(1)H, (13)C, (15)N resonance assignment of the chitin-active lytic polysaccharide monooxygenase BlLPMO10A from Bacillus licheniformis

Biomolecular NMR assignments, 2015-04, Vol.9 (1), p.207-210

2015

Volltextzugriff (PDF)

1 - Is miR-34a the micromanager of cancer stemness and resistance in NSCLC?

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S1-S1

2018

Volltextzugriff (PDF)

A 10 Mbps SiGe BiCMOS Transceiver for Operation Down to Cryogenic Temperatures

2007 IEEE Bipolar/BiCMOS Circuits and Technology Meeting, 2007, p.115-118

2007

Volltextzugriff (PDF)

1003P Baseline (BL) liver function and outcomes in patients (pts) with unresectable hepatocellular carcinoma (HCC) in KEYNOTE-240

Annals of oncology, 2020-09, Vol.31, p.S696-S697

2020

Volltextzugriff (PDF)

1008P IMbrave150: Management of adverse events of special interest (AESIs) for atezolizumab (atezo) and bevacizumab (bev) in unresectable HCC

Annals of oncology, 2020-09, Vol.31, p.S698-S699

2020

Volltextzugriff (PDF)

100P Hepatitis B virus (HBV)-related outcomes in patients (pts) with baseline HBV infection in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC)

Annals of oncology, 2023-10, Vol.34, p.S218-S218

2023

Volltextzugriff (PDF)

1016TiP LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment

Annals of oncology, 2020-09, Vol.31, p.S702-S703

2020

Volltextzugriff (PDF)

103 Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice?

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S36-S36

2013

Volltextzugriff (PDF)

1030-9 An Acute Increase in Hemodynamic Load Produces Plasma Membrane Wounding of Cardiac Myocytes In Vivo

Journal of the American College of Cardiology, 1995-02, Vol.25 (2), p.414A-414A

1995

Volltextzugriff (PDF)

106 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie

Lung cancer (Amsterdam, Netherlands), 2011, Vol.71, p.S37-S37

2011

Volltextzugriff (PDF)

108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

Annals of oncology, 2022-04, Vol.33, p.S81-S82

2022

Volltextzugriff (PDF)

11 - Big applications for a microRNA signature: the diagnostic, prognostic and predictive biomarker potential of a novel 5-miR signature associated with cisplatin resistant NSCLC

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S5-S5

2018

Volltextzugriff (PDF)

113: Do standardised uptake values from PET-CT scans predict EGFR status of lung tumours?

Lung cancer (Amsterdam, Netherlands), 2015, Vol.87, p.S41-S41

2015

Volltextzugriff (PDF)

1132 Safety of fexofenadine HCI in asthmatic patients requiring inhaled corticosteroids in accordance with NHLBI guidlines

Journal of allergy and clinical immunology, 2000, Vol.105 (1), p.S388-S388

2000

Volltextzugriff (PDF)

117: Organ at risk inter- and intra-observer contour variation for lung patients on average versus motion compensated 4DCT

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S52-S53

2017

Volltextzugriff (PDF)

118: Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S53-S54

2017

Volltextzugriff (PDF)

118 Smoking habits in lung cancer patients and their carers and audit of smoking advice given

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S42-S42

2016

Volltextzugriff (PDF)

1199PDPREVALENCE AND CLINICAL OUTCOMES FOR PATIENTS WITH MET PROTEIN EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN EUROPE: RESULTS FROM THE EUROPEAN THORACIC ONCOLOGY PLATFORM LUNGSCAPE PROJECT

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv418-iv418

2014

Volltextzugriff (PDF)

12 month changes in dietary intake of adolescent girls attending schools in low-income communities following the NEAT Girls cluster randomized controlled trial

Appetite, 2014-02, Vol.73, p.147-155

2014

Volltextzugriff (PDF)

120: Impact of introducing intensity modulated radiotherapy (IMRT) on curative-intent radiotherapy for lung cancer – a ‘big data’ analysis

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S54-S55

2017

Volltextzugriff (PDF)

1260POUTCOMES OF ELDERLY PATIENTS (≥70 YO) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A MULTI-INSTITUTIONAL ANALYSIS

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv442-iv442

2014

Volltextzugriff (PDF)

1282PBRAIN METASTASES (BM) IN PATIENTS WITH EGFR MUTATIONS – A REVIEW OF INCIDENCE AND OUTCOMES

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv451-iv451

2014

Volltextzugriff (PDF)

1 – 25 von 4.921

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNucleic Acids Research

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.347)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.965)
Life Sciences & Biomedicine
(2.289)
Humans
(1.573)
Male
(1.005)
Female
(949)
Biological And Medical Sciences
(859)
Medical Sciences
(656)
Adult
(605)
Animals
(581)
Middle Aged
(562)
Physical Sciences
(534)
Aged
(422)
Social Sciences
(275)
Technology
(271)
Oncology
(266)
Mice
(260)
Fundamental And Applied Biological Sciences. Psychology
(247)
Medicin Och Hälsovetenskap
(242)
Chemistry
(240)
Physics
(212)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(96)
Annals Of Oncology
(92)
Physical Review Letters
(84)
Journal Of Thoracic Oncology
(48)
Plos One
(47)
Cancer Research
(46)
Journal Of Clinical Oncology
(44)
Physical Review. C, Nuclear Physics
(42)
The Journal Of Biological Chemistry
(39)
The Astrophysical Journal
(34)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

0505 SLEEP APNEA BREATHING DISTURBANCES ARE ASSOCIATED WITH OBJECTIVE SLEEPINESS INDEPENDENT OF HYPOXIA

1-D and 2-D analyses of weak motion data in Fraser Delta from 1966 Duvall earthquake

1 H, 13 C, 15 N resonance assignment of the apo form of the small, chitin-active lytic polysaccharide monooxygenase JdLPMO10A from Jonesia denitrificans

(1)H, (13)C, (15)N resonance assignment of the chitin-active lytic polysaccharide monooxygenase BlLPMO10A from Bacillus licheniformis

1 - Is miR-34a the micromanager of cancer stemness and resistance in NSCLC?

A 10 Mbps SiGe BiCMOS Transceiver for Operation Down to Cryogenic Temperatures

1003P Baseline (BL) liver function and outcomes in patients (pts) with unresectable hepatocellular carcinoma (HCC) in KEYNOTE-240

1008P IMbrave150: Management of adverse events of special interest (AESIs) for atezolizumab (atezo) and bevacizumab (bev) in unresectable HCC

100P Hepatitis B virus (HBV)-related outcomes in patients (pts) with baseline HBV infection in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC)

1016TiP LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment

103 Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice?

1030-9 An Acute Increase in Hemodynamic Load Produces Plasma Membrane Wounding of Cardiac Myocytes In Vivo

106 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie

108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

11 - Big applications for a microRNA signature: the diagnostic, prognostic and predictive biomarker potential of a novel 5-miR signature associated with cisplatin resistant NSCLC

113: Do standardised uptake values from PET-CT scans predict EGFR status of lung tumours?

1132 Safety of fexofenadine HCI in asthmatic patients requiring inhaled corticosteroids in accordance with NHLBI guidlines

117: Organ at risk inter- and intra-observer contour variation for lung patients on average versus motion compensated 4DCT

118: Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

118 Smoking habits in lung cancer patients and their carers and audit of smoking advice given

1199PDPREVALENCE AND CLINICAL OUTCOMES FOR PATIENTS WITH MET PROTEIN EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN EUROPE: RESULTS FROM THE EUROPEAN THORACIC ONCOLOGY PLATFORM LUNGSCAPE PROJECT

12 month changes in dietary intake of adolescent girls attending schools in low-income communities following the NEAT Girls cluster randomized controlled trial

120: Impact of introducing intensity modulated radiotherapy (IMRT) on curative-intent radiotherapy for lung cancer – a ‘big data’ analysis

1260POUTCOMES OF ELDERLY PATIENTS (≥70 YO) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A MULTI-INSTITUTIONAL ANALYSIS

1282PBRAIN METASTASES (BM) IN PATIENTS WITH EGFR MUTATIONS – A REVIEW OF INCIDENCE AND OUTCOMES

Aktive Filter

Suchergebnisse filtern